Independent Antibody Assessments

About NordiQC

nordiqcNordiQC is an independent organization based out of Denmark whose objective is to promote immunohistochemistry quality by arranging tests for pathology laboratories, assessing tissue stains, giving recommendations for improvement, and providing quality protocols. NordiQC runs a series of tests on a variety of antibody markers throughout the year. Epitomics participated in several tests with the results indicated below. For more information, click here.

As a point of reference, results, judged by NordiQC, fall into one of 4 categories:

Assessment Method

- Optimal staining: The staining is considered perfect or close to perfect in all of the included tissues.
- Good staining: The staining is considered fully acceptable in all of the included tissues. However, the protocol may be optimized to ensure the best staining intensity and signal-to-noise ratio.
- Borderline staining: The staining is considered insufficient, e.g., because of a generally too weak staining or a false negative staining of one of the included tissues, or a false positive staining reaction. The protocol should be optimized.
- Poor staining: The staining is considered very insufficient e.g., because of false negative staining of several of the included tissues, or a marked false positive staining reaction. An optimization of the protocol is urgently needed.

For more information, click here.

Results of Assessment

The following Epitomics antibodies were selected for testing by NordiQC. Images from those assessments are provided where available.

Optimal Staining

  

 

    
msh6

Target: MSH6
EP Clone ID: EP49
Tissue: Tonsil
Epitomics product page: here
NordiQC assessment : here

 her2

Target: Her2/ErbB2
EP Clone ID: EP3
Tissue: Breast Cancer
Epitomics product page: here
NordiQC assessment : here
           
cd99  

Target: CD99
EP Clone ID: EP8
Tissue: Esophagus
Epitomics product page: here
NordiQC assessment: here

 cd20  

Target: CD20
EP Clone ID: EP7
Tissue: Breast Cancer
Epitomics product page: here
NordiQC assessment : here
           
ck8  

Target: CK8
EP Clone ID: EP17
Tissue: Breast ductal carcinoma
Epitomics product page: here
NordiQC assessment: here

 ck19  

Target: CK19
EP Clone ID: EP72
Tissue: Tonsil
Epitomics product page: here
NordiQC assessment: here
           
ck8  

Target: PR
EP Clone ID: EP2
Tissue: Breast
Epitomics product page: here
NordiQC assessment: here

      
           

Good Staining

         
cd23  

Target: CD23
EP Clone ID: EP75
Tissue: Tonsil
Epitomics product page: here
NordiQC assessment: here

 cd5  

Target: CD3
EP Clone ID: EP41
Tissue: Tonsil
Epitomics product page: here
NordiQC assessment: here
           
cd5  

Target: CD5
EP Clone ID: EP77
Tissue: Tonsil
Epitomics product page: here
NordiQC assessment: here

 s100  

Target: S100
EP Clone ID: EP32
Tissue: Melanoma stained with
anti-S100
Epitomics product page: here
NordiQC assessment: here
           
cd5  

Target: CK20
EP Clone ID: EP23
Tissue: Colon Cancer
Epitomics product page: here
NordiQC assessment: here

 s100  

Target: GCDFP-15
EP Clone ID: EP95
Tissue: Breast
Epitomics product page: here
NordiQC assessment: here
           

 

CD99 MSH6